NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Australia flag Australia · Delayed Price · Currency is AUD
0.105
+0.005 (5.00%)
Mar 10, 2026, 9:59 AM AEST
208.82%
Market Cap 33.26M
Revenue (ttm) 317.91K
Net Income (ttm) -3.18M
Shares Out 332.58M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,000
Average Volume 152,350
Open 0.105
Previous Close 0.100
Day's Range 0.105 - 0.105
52-Week Range 0.034 - 0.260
Beta 1.08
RSI 36.29
Earnings Date Feb 25, 2026

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol NSB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.